Profound Medical PROF Cash Flow Statement (2022-2026)

NASDAQ PROF
$6.80 -0.01 (-0.15%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Profound Medical Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Profound Medical reported cash from operations of -$11.34M and free cash flow of -$11.34M for the quarter ended Jun 2026, up 17.5% year over year. This cash flow statement covers 12 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -6.58M-6.92M-9.37M-1.24M-10.72M-15.71M-7.98M-2.63M-7.05M-9.55M
Share-based CompensationStock Comp. 1.51M1.47M0.77M0.77M0.60M0.44M2.11M2.15M2.15M1.38M2.20M2.15M
Deferred Taxes 0.00M0.01M
Cash from OperationsCash from Ops. -4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M-6.57M-8.58M-11.34M
Change in Working Capital
Change in ReceivablesChange Receivables -1.32M0.84M-0.30M0.59M-1.09M-1.36M3.36M-0.74M2.24M0.23M
Change in InventoryChange Inventory 0.18M-0.01M-0.34M-0.48M0.98M1.74M-0.13M0.23M1.00M1.69M
Change in Accured ExpensesChange Accured Exp. -0.57M0.06M0.68M0.65M0.30M0.24M-0.21M0.04M0.31M-1.30M
Change in TaxesChange Taxes 0.01M-0.02M0.00M0.03M
Financing Activities
Other financing activitiesOther financing 1.86M3.04M
Cash from Financing ActivitiesCash from Financing 20.46M-0.60M-0.59M35.44M-0.29M41.43M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued 0.06M0.95M0.19M0.24M0.07M
Net Equity Issued and RepurchasedNet Equity Issued 22.94M39.17M
Additional items
Exchange Rate EffectFX Effect -0.96M-0.28M0.46M-1.77M0.09M2.51M-0.76M0.28M-0.84M-0.69M
Change in Cash 15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M34.62M-8.58M-11.34M
Free Cash FlowFCF -4.53M-6.22M-6.83M-5.88M-8.28M-13.74M-9.61M-6.57M-8.58M-11.34M
Net Cash FlowNCF 15.93M-6.82M-7.42M29.56M-8.57M-13.74M-9.61M34.86M-8.58M-11.34M